ERIC RUTSTEIN: Open Payments
NPI 1639265333 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,900 in 87 payments from 14 companies in 2025. Trend: 2023 $8,372 · 2024 $3,403 · 2025 $2,900
Food & beverage: $2,900
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $500 |
| Vanda Pharmaceuticals Inc. | 10 | $487 |
| Otsuka America Pharmaceutical, Inc. | 8 | $394 |
| Neurocrine BioSciences, Inc. | 14 | $331 |
| Teva Pharmaceuticals USA, Inc. | 12 | $305 |
| Axsome Therapeutics, Inc. | 8 | $300 |
| Alkermes, Inc. | 9 | $241 |
| Lundbeck LLC | 4 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $91 |
| Almatica Pharma LLC | 2 | $42 |
Products named: CAPLYTA, REXULTI, FANAPT, INGREZZA, AUSTEDO XR, Auvelity, HETLIOZ, ARISTADA.
Industry payments across FL — which companies pay providers there.
